LuTectomy – LuPSMA in the very early stage of prostate cancer – what were the initial results? What difference does it make, choosing the right PSMA tracer? And how should PSMA-PET be used, according to the radiation oncologist? Listen to our eminent guests Declan Murphy, Stefano Fanti, Louise Emmett, Gert de Meerleer and Ken Herrmann talking about the future of theragnostics in urology, from the EAU 22 Congress in Amsterdam.

 

Guests: Ken Herrmann, Gert de Meerleer, Louise Emmett, Stefano Fanti and Declan Murphy.

By: Lisa Gruschy and Gustav Widar

Contact us: podcast@samnordic.se

For more info, visit www.samnordic.se

Rss Apple Podcaster
Podden och tillhörande omslagsbild på den här sidan tillhör SAM Nordic. Innehållet i podden är skapat av SAM Nordic och inte av, eller tillsammans med, Poddtoppen.